Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.79 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | DPYD | Q12882 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | MTOR | P42345 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | HBB | P68871 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thymine SCHEMBL23794979 | 0.89 | ATAD2 (0.91) | ATAD2GAAMAPTDPYDLMNA | |
| Thymine SCHEMBL750450 | 0.89 | ATAD2 (1.00) | ATAD2GAAMAPTDPYDLMNA | |
| Thymine SCHEMBL5235 | 0.89 | — | — | |
| Thymine SCHEMBL17201833 | 0.89 | ATAD2 (1.00) | ATAD2GAAMAPTDPYDLMNA | |
| Thymine SCHEMBL29669526 | 0.89 | — | — | |
| Thymine SCHEMBL15323914 | 0.89 | ATAD2 (1.00) | ATAD2GAAMAPTDPYDLMNA | |
| Thymine SCHEMBL3025204 | 0.87 | ATAD2 (0.86) | ATAD2GAAMAPTDPYDLMNA | |
| Thymine SCHEMBL8304490 | 0.87 | ATAD2 (0.86) | ATAD2GAAMAPTDPYDLMNA | |
| Thymine SCHEMBL8649294 | 0.87 | ATAD2 (0.95) | ATAD2GAAMAPTDPYDLMNA | |
| Thymine SCHEMBL5176783 | 0.87 | ATAD2 (0.95) | ATAD2GAAMAPTDPYDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630851-B2 | Polynucleotide modification methods | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-05-19 | — | — | US | claimed |
| US-20260098287-A1 | METHOD AND KIT FOR REGENERATING REUSABLE INITIATORS FOR NUCLEIC ACID SYNTHESIS | CHENG-YAO CHEN (TW) | 2026-04-09 | — | — | US | claimed |
| US-12577615-B2 | Methods for the detection of a nucleic acid | RHODX, INC. (US) | 2026-03-17 | — | — | US | claimed |
| WO-2025245282-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF PROTEIN ANALYTES | RANGE BIOTECHNOLOGIES, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| US-20250340935-A1 | METHODS FOR THE DETECTION OF A NUCLEIC ACID | RHODX INC (US) | 2025-11-06 | — | — | US | claimed |
| EP-4569132-A2 | METHOD, KIT AND SYSTEM FOR END LABELING OF NUCLEIC ACIDS | Chen, Cheng-Yao (TW) | 2025-06-18 | — | — | EP | claimed |
| WO-2025021984-A1 | METHOD FOR GENERATING A PLURALITY OF POLYNUCLEOTIDES | DNA SCRIPT (FR) | 2025-01-30 | — | — | WO | claimed |
| US-20250019744-A1 | METHOD, KIT AND SYSTEM FOR END LABELING OF NUCLEIC ACIDS | Chen, Cheng-Yao (TW) | 2025-01-16 | — | — | US | claimed |
| US-12084715-B1 | Methods and systems for reducing artifactual antisense products | 10X GENOMICS, INC. (US) | 2024-09-10 | — | — | US | claimed |
| US-20240175010-A1 | Methods of Library Preparation | ILLUMINA, INC. (US) | 2024-05-30 | — | — | US | claimed |
| WO-2002076280-A2 | METHODS AND KITS FOR DETERMING A RISK TO DEVELOP CANCER, FOR EVALUATING AN EFFECTIVENESS AND DOSAGE OF CANCER THERAPY AND FOR CORRELATING BETWEEN AN ACTIVITY OF A DNA REPAIR ENZYME AND A CANCER | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2002-10-03 | — | — | WO | claimed |
| US-20020055104-A1 | Nucleic acid binding site assay and selection method | GENELABS TECHNOLOGIES, INC. | 2002-05-09 | — | — | US | claimed |
| WO-2001051669-A9 | NUCLEIC ACID BINDING ASSAY AND SELECTION METHOD | GENELABS TECH INC (US) | 2001-11-29 | — | — | WO | claimed |
| WO-2001051669-A2 | NUCLEIC ACID BINDING ASSAY AND SELECTION METHOD | GENELABS TECHNOLOGIES, INC. (US) | 2001-07-19 | — | — | WO | claimed |
| US-5906918-A | QUANTITATING BASE MODIFICATIONS IN SAMPLE DNA BY ENDONUCLEASE DIGESTION TO DINUCLEOSIDE MONOPHOSPHATES, DEPHOSPHORYLATION, LABELING SAMPLE AND INTERNAL STANDARD DNA, ADDING COMIGRATING CARRIERS, SEPARATING SAMPLE/CARRIER FROM STANDARD/CARRIER | HEALTH RESEARCH INC. (US) | 1999-05-25 | — | — | US | claimed |
| US-5871992-A | REPAIR OF DNA WITH ENZYME OF GLYCOSYLASE/AP LYASE ALSO FUSION PROTEINS | NEW YORK UNIVERSITY (US) | 1999-02-16 | — | — | US | claimed |
| US-5763180-A | In vitro assay for carcinogens using phenotypic transformation of human cells | VIRATEST CARCINOGEN MONITORING LTD. (CA) | 1998-06-09 | — | — | US | claimed |
| WO-1997031612-A2 | MAMMALIAN ENDONUCLEASE III, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF | NEW YORK UNIVERSITY (US) | 1997-09-04 | — | — | WO | claimed |
| US-5552285-A | DIAGNOSIS AND MONITORING OF INFLAMMATORY AND AUTOIMMUNE DISEASES | NEW YORK UNIVERSITY (US) | 1996-09-03 | — | — | US | claimed |
| WO-1992015707-A1 | IMMUNOASSAY FOR ANTIBODIES TO OXIDIZED DNA AND USES THEREOF | NEW YORK UNIVERSITY (US) | 1992-09-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577615-B2 | Methods for the detection of a nucleic acid | POLRMT, RNGTT, RNASE1 | ATAD2 4183/4885GAA 663/4885MAPT 4803/4885 |
| US-12630851-B2 | Polynucleotide modification methods | PNP, NT5C3B, UNG | ATAD2 2669/4885GAA 1181/4885MAPT 3328/4885 |
| US-20260098287-A1 | METHOD AND KIT FOR REGENERATING REUSABLE INITIATORS FOR NUCLEIC ACID SYNTHESIS | DNMT3L, ADAR, UNG | ATAD2 352/4885GAA 391/4885MAPT 4124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.